knowledge -WSS

knowledge

author：knowledge 2025-09-29 19:58:05 - browse：62514

Sen. Bill Cassidy, R-La., listens during a Senate Health, Education, Labor, and Pensions Committee hearing. -- health policy coverage from STAT — Sen. Bill Cassidy (R-La.) Stefani Reynolds/The New York Times via AP

WASHINGTON — The top-ranking Republican on the Senate health committee is launching an investigation into two hospitals’ use of a government program that provides big drug discounts in return for serving low-income communities.

At the foundation of the debate over the so-called 340B program is whether Congress intended it to directly benefit low-income and uninsured patients or whether it was meant to help finance those hospitals, which could use the money as they see fit to add services.

Hospitals say they use the money to provide such services as free care for uninsured patients, free vaccinations, mental health clinics, and community health programs. But drugmakers have long argued that hospitals and chain pharmacies abuse the program and divert its cash flows to other uses. They also say the 340B program fuels the consolidation of health care systems as hospitals buy up private doctor practices to expand the 340B revenue stream.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Thermo Fisher plant for manufacturing gene therapies to expand

WSS

Lasker Awards 2023: Winners in biomedical research

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Beyond aggravation: Constipation is an American epidemic

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Asahi Kasei to buy Calliditas, picking up kidney disease drug

explore

knowledge

entertainment

Supreme Court strikes down use of affirmative action

Drug for rare kidney disease narrowly misses mark in clinical trial

As demand for Covid shots wanes, Moderna seeks its next success

Drug for rare kidney disease narrowly misses mark in clinical trial

Medical leaders decry Supreme Court decision on affirmative action

It's been 20 years since Dolly the sheep. Where's my clone?

Continuity nursing helped my family in our darkest PICU moments

CDC advisers recommend seasonal use of Pfizer RSV shot

Cancer drug shortages should be causing more outrage

Unmasking the 'centricity' illusion in clinical trials

focus

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Lawsuit challenges CMS nursing home minimum staffing rule

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

CDC's new outbreak response network to include Northeastern

Stroke rates rising, especially in working

Wikipedia

knowledge

focus

explore